Products

 

Direct Patient Assistance

The health care needs of people throughout the world are diverse - from those of societies seeking to increase the effectiveness of health care through sophisticated, innovative technology to the needs of communities concerned with securing basic health care to help keep people alive. In 2006, we donated over $314 million in products to patients and agencies throughout the world.

Lilly Cares™

Lilly Cares is a patient assistance program provided by Lilly through the Lilly Cares Foundation. As part of the company's efforts to provide access to our products for legal U.S. residents regardless of their ability to pay, we created a program to offer free medication, through physicians, to patients who are otherwise unable to obtain our products. Lilly Cares assists patients who are uninsured and whose income is less than 200 percent of the federal poverty level. In 2006, the Lilly Cares Foundation, Inc. program responded to over 162,000 patients, valued at more than $161,000,000, for Lilly products. Most Lilly products are available through the program.

Eligibility is based on the patient's inability to pay and lack of third-party drug payment assistance, including insurance, Medicaid and government, community, or private programs and cannot be eligible for Medicare. Applications are available to anyone and must be completed and signed by the patient and the physician. Patients can download a blank application from the Lilly Cares website or applications can be faxed to you by calling 1-800-545-6962.

back to the top

LillyMedicareAnswers Program - IMPORTANT UPDATE

Eli Lilly and Company offers applications for enrollment in the LillyMedicareAnswers™ program by calling 1-877-795-4559 or 1-877-RXLilly, or downloading from the www.LillyMedicareAnswers.com website.

Access to affordable medications is a top priority for Eli Lilly and Company. LillyMedicareAnswers is a new patient assistance program that provides eligible Medicare recipients access to affordable medications outside of their Medicare Part D plan.

The LillyMedicareAnswers program provides assistance to eligible patients prescribed FORTEO® (teriparatide [rDNA origin] injection), ZYPREXA® (olanzapine) or Humatrope® (somatropin [rDNA origin] for injection).

Some of the key eligibility criteria for the program are:

  • Enrollment in a Medicare Part D plan
  • Not eligible for both Medicare and Medicaid (non-dual eligible people)
  • Income at or below 200 percent of the Federal Poverty Level (FPL)
  • Proof of low-income subsidy denial
  • Signed certification that the patient will not claim or submit any cost incurred or associated with the medications
    provided under the LillyMedicareAnswers program towards their true-out-of-pocket-cost (“TROOP”) calculation or submit any claim for reimbursement for the medications

Once patients have enrolled in the LillyMedicareAnswers program, they are eligible to participate in the program for the rest of the calendar year, as long as they have a valid prescription for the medication. Patients must re-enroll in the program each year. Patient's medications will be shipped directly to the patient’s home.

For further details about the program and application materials, please visit the LillyMedicalAnswers website or call toll free 1-877-RX-LILLY (1-877-795-4559)

back to the top

Lilly Oncology

For Gemzar® and Alimta®, Lilly provides assistance with obtaining reimbursement. If patients do not have insurance and are unable to obtain other financial assistance, they may be eligible to obtain Lilly oncology products through our patient assistance program. For information about obtaining reimbursement assistance and patient assistance, visit the Gemzar or Alimta websites.

back to the top

Xigris Treatment Support Program

The Xigris Treatment Support Program assists certain health-care institutions that have provided urgent, potentially life-saving treatment to patients who do not have medical insurance, other forms of reimbursement or other means of financial support. Product usage, and individual patients, must meet certain eligibility requirements. Heathcare professionals can access information on the program via the Xigris website.

back to the top

Humatrope

Reimbursement - For Health Care Professionals
Eli Lilly provides healthcare professionals with a reimbursement center and a statement of medical necessity (SMN) form. The SMN form is designed to help organize and enhance the reimbursement process. To assist health care professionals and their patients, we have prepared information and the form for them to use.


Humatrope Access Program
For patients prescribed Humatrope who do not have adequate insurance and/or who do not have other financial assistance, the Humatrope Access Program may provide eligible patients a full supply of Humatrope for a twelve-month period. More information can be obtained by calling 1-800-642-2340.

 

back to the top

Partnership for Prescription Assistance, PPARx

The Partnership for Prescription Assistance, PPARx Web site, PPARx.com, provides a list of member companies that provide patient assistance programs along with Web links through helpingpatients.com. April 5, 2007 marked the two-year anniversary of the PPA, and a successful outcome of connecting more than 3.5 million lower income uninsured and underinsured people to one or more patient assistance programs.

back to the top